ArticleGigaScience2026
ChatMDV: reducing technical barriers in bioinformatics analysis using large language models.
Article in GigaScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundThe rapid advancement in single-cell, spatial omics, imaging, and genomic technologies requires robust analytical and visualisation platforms capable of managing complex biological data. Tools such as Multi-Dimensional Viewer (MDV) offer comprehensive interfaces for data exploration but often require advanced computational expertise and manual configuration to generate visualisation outputs, limiting accessibility for many users.
resultsWe present ChatMDV, a natural language interface integrated with MDV that enables users to generate high-quality, interactive visualisations and analyses through natural language commands. ChatMDV employs a retrieval-augmented generation pipeline in combination with large language models to translate user queries into executable, reproducible Python code and interactive output. This conversational layer facilitates both exploratory and targeted analyses in diverse biological domains. We demonstrate ChatMDV's capabilities using 3 datasets of increasing complexity: the Peripheral Blood Mononuclear Cells 3K single-cell RNA-sequencing (scRNA-seq) dataset, the lung cancer atlas scRNA-seq dataset included in the Human Cell Atlas, and the longitudinal TAURUS study scRNA-seq dataset. Across all use cases, ChatMDV produced high-quality, reproducible visualisations from simple natural language queries, achieving a high semantic success rate between 79% and 97% when visualising the datasets.
conclusionsBy bridging the gap between natural language processing and bioinformatics visualisation, ChatMDV reduces technical barriers, enhances reproducibility, and supports more inclusive scientific inquiry. Its modular design and adherence to Findability, Accessibility, Interoperability, and Reuse (FAIR) principles make it a scalable and adaptable framework for accelerating biological data analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.